ARTICLE | Company News
CoPlex, Hawthorn deal
September 19, 2011 7:00 AM UTC
CoPlex granted Hawthorn exclusive, worldwide rights to develop and commercialize hawAD14. Hawthorn will be responsible for conducting and funding all clinical development. The small molecule calcium...